Abstract
S3 nerve root neuromodulation is becoming an accepted therapy for individuals afflicted with lower urinary tract symptoms, such as idiopathic urinary urge incontinence, frequency, urgency, and urinary retention, who fail current standard therapies. This patient population is difficult to treat, and this therapy offers an option that can restore quality of life to these individuals. While the precise pathophysiologic mechanisms underlying these voiding symptoms is unknown based on the physiology of bladder function, it is logical to conclude that they relate to some aberration of the neuromuscular apparatus of the bladder and/or its outlet (the urethra). These pathophysiologic defects are not overtly manifested outside the lower urinary tract because these patients routinely do not have any apparent neurologic deficits. The fact that S3 neuromodulation can clinically improve these lower urinary tract symptoms would support the notion that the neural regulation of the bladder is somehow altered in these patients. This paper presents a review of the current knowledge regarding sacral neuromodulation in treatment of non-neurogenic voiding dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Readings
Schmidt RA, Tanagho EA: Feasibility of controlled micturition through electric stimulation. Urol Int 1979, 34:199–230.
Tanagho EA, Schmidt RA: Bladder pacemaker: scientific basis and clinical future. Urology 1982, 20:614–619.
Tanagho EA, Schmidt RA: Electrical stimulation in the clinical management of the neurogenic bladder. J Urol 1998, 140:1331–1339.
Schmidt RA, Senn E, Tanagho EA: Functional evaluation of sacral nerve root integrity. Report of a technique. Urology 1990, 35:388–392. This is the original paper that describes peripheral nerve evaluation of S3 nerve root. It provided the basis for development of the therapy of sacral neuromodulation for non-neurogenic voiding dysfunction.
Cheng CL, Ma CP, de Groat WC: Effect of capsaicin on micturition and associated reflexes in chronic spinal rats. Brain Res 1995, 678:40–48.
Yoshimura N, Erdman SL, Snider MW, de Groat WC: Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder. Neuroscience 1998, 83:633–643.
Chai TC, Gray ML, Steers WD: The incidence of a positive ice water test in bladder outlet obstructed patients: evidence for bladder neural plasticity. J Urol 1998, 160:34–38. This paper shows that C fiber-mediated micturition reflex may occur in disease states such as spinal cord injury and bladder outlet obstruction.
Barrington F: The component reflexes of micturition in the cat, Parts I and II. Brain 1931, 54:177.
Jung SY, Fraser MO, Ozawa H, et al.: Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol 1999, 162:204–212. This is a recent paper describing the relationship between urethral afferent and bladder activity, which is important because we do not know very much about urethral afferent activity nor about reflexes mediated by this activity.
Schmidt RA, Jonas U, Oleson KA, et al.: Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol 1999, 162:352–357.
Hassouna MM, Siegel SW, Nyeholt AA, et al.: Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol 2000, 163:1849–1854.
Jonas U, Fowler CJ, Chancellor MB, et al.: Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol 2001, 165:15–19. This paper, along with references [10] and [11], represents the modern clinical series of using S3 neuromodulation in treating idiopathic urinary urge incontinence, frequency-urgency syndrome, and nonobstructive retention. The investigators designed a robust clinical study (the design was identical in all three papers; the only difference was the inclusion criteria) utilizing randomization of controls (delayed neuromodulation group), standardized data collection sets, and well-defined treatment outcome parameters.
Schultz-Lampel D, Jiang C, Lindstrom S, Thuroff JW: Experimental results on mechanisms of action of electrical neuromodulation in chronic urinary retention. World J Urol 1998, 16:301–304.
Fowler CJ, Christmas TJ, Chapple CR, et al.: Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ 1988, 297:1436–1438.
Elabbady AA, Hassouna MM, Elhilali MM: Neural stimulation for chronic voiding dysfunctions. J Urol 1994, 152:2076–2080.
Schmidt RA, Vapnek JM, Tanagho EA: Restoration of voiding in chronic urinary retention using neuroprosthesis. World J Urol 1991, 9:142–144.
Fall M, Lindstrom S: Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis. Urol Clin North Am 1994, 21:131–139.
Melzack R, Wall PD: Pain mechanisms: a new theory. Science 1965, 150:971–979.
Wang Y, Hassouna MM: Neuromodulation reduces c-fos gene expression in spinalized rats: a double-blind randomized study. J Urol 2000, 163:1966–1970.
Birder LA, de Groat WC: Induction of c-fos expression in spinal neurons by nociceptive and nonnociceptive stimulation of LUT. Am J Physiol 1993, 265:R326-R333.
Chai TC, Zhang C, Warren JW, Keay S: Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology 2000, 55:643–646. This article, along with references [22-24], suggests what the next phase of sacral neuromodulation will be. New indications are being explored. The mechanism of neuromodulation in altering the biochemical phenotype of the target organ is suggested. Modified approaches to neuromodulation may make this therapy easier and more acceptable to patients and clinicians.
Maher CF, Carey MP, Dwyer PL, Schluter PL: Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol 2001, 165:884–886.
Chartier-Kastler EJ, Ruud Bosch JL, Perrigot M, et al.: Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol 2000, 164:1476–1480.
Chai TC, Mamo GJ: Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation. Urology 2001, 58:786–790.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MaLossi, J., Chai, T.C. Sacral neuromodulation for the treatment of bladder dysfunction. Curr Urol Rep 3, 61–66 (2002). https://doi.org/10.1007/s11934-002-0012-9
Issue Date:
DOI: https://doi.org/10.1007/s11934-002-0012-9